NuSirt Biopharma Technology Presented At American Diabetes Association Scientific Sessions
7/8/2014 10:51:40 AM
NuSirt Biopharma, Inc., today announced that two papers presented at the American Diabetes Association (ADA) 74th Scientific Sessions demonstrate that the company’s patented technology enhances the ability of a common Type 2 diabetes medication to better control blood sugar.
Help employers find you! Check out all the jobs and post your resume.
comments powered by